Psyence Biomedical Ltd Stock Probability of Future Stock Price Finishing Under 2.82

PBM Stock  USD 2.52  0.30  10.64%   
Psyence Biomedical's future price is the expected price of Psyence Biomedical instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Psyence Biomedical Ltd performance during a given time horizon utilizing its historical volatility. Check out Psyence Biomedical Backtesting, Psyence Biomedical Valuation, Psyence Biomedical Correlation, Psyence Biomedical Hype Analysis, Psyence Biomedical Volatility, Psyence Biomedical History as well as Psyence Biomedical Performance.
  
As of the 4th of December 2024, Price Earnings Ratio is likely to grow to -10.35. In addition to that, Price Book Value Ratio is likely to grow to -48.24. Please specify Psyence Biomedical's target price for which you would like Psyence Biomedical odds to be computed.

Psyence Biomedical Target Price Odds to finish below 2.82

The tendency of Psyence Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to stay under $ 2.82  after 90 days
 2.52 90 days 2.82 
about 14.13
Based on a normal probability distribution, the odds of Psyence Biomedical to stay under $ 2.82  after 90 days from now is about 14.13 (This Psyence Biomedical Ltd probability density function shows the probability of Psyence Stock to fall within a particular range of prices over 90 days) . Probability of Psyence Biomedical price to stay between its current price of $ 2.52  and $ 2.82  at the end of the 90-day period is about 1.32 .
Considering the 90-day investment horizon Psyence Biomedical has a beta of 0.0638 indicating as returns on the market go up, Psyence Biomedical average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Psyence Biomedical Ltd will be expected to be much smaller as well. Additionally Psyence Biomedical Ltd has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.
   Psyence Biomedical Price Density   
       Price  

Predictive Modules for Psyence Biomedical

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Psyence Biomedical. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.183.6312.17
Details
Intrinsic
Valuation
LowRealHigh
0.122.4210.96
Details
Naive
Forecast
LowNextHigh
0.063.0911.63
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
3.183.614.04
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Psyence Biomedical. Your research has to be compared to or analyzed against Psyence Biomedical's peers to derive any actionable benefits. When done correctly, Psyence Biomedical's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Psyence Biomedical.

Psyence Biomedical Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Psyence Biomedical is not an exception. The market had few large corrections towards the Psyence Biomedical's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Psyence Biomedical Ltd, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Psyence Biomedical within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
-3.11
β
Beta against Dow Jones0.06
σ
Overall volatility
4.93
Ir
Information ratio -0.34

Psyence Biomedical Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Psyence Biomedical for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Psyence Biomedical can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Psyence Biomedical generated a negative expected return over the last 90 days
Psyence Biomedical has high historical volatility and very poor performance
Psyence Biomedical has a very high chance of going through financial distress in the upcoming years
Reported Net Loss for the year was (51.16 M) with profit before taxes, overhead, and interest of 0.
Psyence Biomedical Ltd has about 281.63 K in cash with (2.95 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.02.
Psyence Biomedical has a frail financial position based on the latest SEC disclosures
Roughly 58.0% of the company outstanding shares are owned by corporate insiders
Latest headline from gurufocus.com: Psyence Biomedical Issues Shareholder Update Highlighting Recent Progress

Psyence Biomedical Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Psyence Stock often depends not only on the future outlook of the current and potential Psyence Biomedical's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Psyence Biomedical's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding6.5 M
Cash And Short Term Investments733.2 K

Psyence Biomedical Technical Analysis

Psyence Biomedical's future price can be derived by breaking down and analyzing its technical indicators over time. Psyence Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Psyence Biomedical Ltd. In general, you should focus on analyzing Psyence Stock price patterns and their correlations with different microeconomic environments and drivers.

Psyence Biomedical Predictive Forecast Models

Psyence Biomedical's time-series forecasting models is one of many Psyence Biomedical's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Psyence Biomedical's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Psyence Biomedical

Checking the ongoing alerts about Psyence Biomedical for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Psyence Biomedical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Psyence Biomedical generated a negative expected return over the last 90 days
Psyence Biomedical has high historical volatility and very poor performance
Psyence Biomedical has a very high chance of going through financial distress in the upcoming years
Reported Net Loss for the year was (51.16 M) with profit before taxes, overhead, and interest of 0.
Psyence Biomedical Ltd has about 281.63 K in cash with (2.95 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.02.
Psyence Biomedical has a frail financial position based on the latest SEC disclosures
Roughly 58.0% of the company outstanding shares are owned by corporate insiders
Latest headline from gurufocus.com: Psyence Biomedical Issues Shareholder Update Highlighting Recent Progress
When determining whether Psyence Biomedical is a strong investment it is important to analyze Psyence Biomedical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Psyence Biomedical's future performance. For an informed investment choice regarding Psyence Stock, refer to the following important reports:
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Psyence Biomedical. If investors know Psyence will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Psyence Biomedical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(7.82)
Return On Assets
(1.26)
The market value of Psyence Biomedical is measured differently than its book value, which is the value of Psyence that is recorded on the company's balance sheet. Investors also form their own opinion of Psyence Biomedical's value that differs from its market value or its book value, called intrinsic value, which is Psyence Biomedical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Psyence Biomedical's market value can be influenced by many factors that don't directly affect Psyence Biomedical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Psyence Biomedical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Psyence Biomedical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Psyence Biomedical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.